BCI & Neuroscience

Brain-computer interfaces in early 2026 are at an inflection point. The clinical layer is consolidating around two validated devices: Neuralink's PRIME study (~20 patients, thought-controlled computing, UK/UAE expansion) and Synchron's Stentrode (first FDA-approved implanted BCI to meet a feasibility primary endpoint, $200M Series D for pivotal trials). Meanwhile, the research layer is producing increasingly precise taxonomies of the problem space — how signal acquisition, paradigm design, and AI decoding interact — and benchmarks are advancing: speech BCI has hit 10% word error rate, and inner speech decoding from motor cortex has been demonstrated in 4 patients.

Three new sources added April 2026 fill in critical structural knowledge: a comprehensive review of signal acquisition methods and interaction paradigms (CUHK Shenzhen, arXiv 2503.16471), a clinical applications systematic review covering motor rehabilitation through neuropsychiatric applications (Deng et al., ScienceDirect 2025), and an AI benchmark review comparing CNN/RNN/Transformer approaches for EEG-based motor imagery (VIT Chennai, ScienceDirect 2025).

Frontier — What's Moving Now

• Synchron primary endpoint met — 12-month data, 6 patients, $200M Series D for pivotal trials.
• Neuralink ~20 patients — UK/UAE expansion; FDA breakthrough designation; practical daily use demonstrated.
• Speech BCI: 10% WER — BIT framework bridges neural signals to text via audio LLMs.
• Inner speech decoded — Stanford shows thought patterns decodable from motor cortex.
• AI for EEG approaching ceiling in lab conditions — 99-100% accuracy for constrained tasks; generalizability is the unsolved problem.
• Closed-loop neurostimulation emerging — Epilepsy (Neuropace RNS), Parkinson's adaptive DBS, depression biomarker-guided TMS.

Concept Map

Concepts

Entities

Timeline

See timeline.md for chronological developments (2004 through 2026).

Research Frontier

See frontier.md for active research directions, breakthroughs, and knowledge gaps.

Sources